Clinical Trials Directory

Trials / Unknown

UnknownNCT01373697

Study to Assess the Efficacy and Safety of Ibuprofen 50 mg/g Gel Compared to Profenid 25mg/g Gel

Clinical Multicenter, Phase III, Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Ibuprofen 50mg/g Gel in the Treatment of Patients With Muscle Pain, Joint, or Pain Caused by Sprains, Contusions, Tendinitis, or Myofascial Compared to Profenid ® 25mg/g. Gel

Status
Unknown
Phase
Phase 3
Study type
Interventional
Enrollment
144 (estimated)
Sponsor
Laboratório Teuto Brasileiro S/A · Industry
Sex
All
Age
12 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to determine that ibuprofen 50mg/g gel is effective and safety treating patients with muscle aches, joint pains or due to sprains, bruises, tendinitis or myofascial compared to Profenid 25mg/g gel.

Detailed description

The main objective of this study is to evaluate the efficacy of ibuprofen 50 mg/g gel in the treatment of patients with muscle, joint pain caused by sprains, contusions, tendinitis, or myofascial compared to Profenid 25mg/g gel.

Conditions

Interventions

TypeNameDescription
DRUGIbuprofenApply the gel at the site of pain or injury, massaging gently to promote penetration of 8 in 8 hours for 5 days. Leave the gel on the premises at least 4 hours before removal
DRUGProfenidApply the gel on the spot of pain or injury, massaging slightly to facilitate the penetration of 8 in 8 hours during 5 days. Leave the gel on the the site at least 4 hours before removal

Timeline

Start date
2011-06-01
Primary completion
2011-08-01
Completion
2011-08-01
First posted
2011-06-15
Last updated
2011-06-15

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT01373697. Inclusion in this directory is not an endorsement.